{
    "nctId": "NCT02239601",
    "briefTitle": "Chemotherapy Induced Peripheral Neuropathy. Could Physical Therapy Help Treat Symptoms?",
    "officialTitle": "Chemotherapy - Induced Peripheral Neuropathy (CIPN). Could There be a Role for Physical Therapy Treatment?",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Peripheral Neuropathy, Secondary to Drugs or Chemicals",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 61,
    "primaryOutcomeMeasure": "Percentage of Participants With 'Pain' or 'no Pain' as Measured by the Numeric Pain Rating Scale",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients diagnosed with stage I-III breast cancer undergoing regular docetaxel treatment either docetaxel-cyclophosphamide (TC) or 5FU-epirubicin-cyclophosphamide-docetaxel (FEC-D).\n* Patients that have not had chemotherapy in the past and do not have identified risk factors (listed below in the exclusion criteria).\n* All patients must be able to communicate in english or be able to have a translator present at all appointments.\n\nExclusion Criteria:\n\n* Patients diagnosed with stage IV breast cancer or who have co-morbid conditions that are known to cause peripheral neuropathic symptoms, including previous chemotherapy, exposure to toxins (such as lead), Diabetes, Shingles, B12 deficiency, Alcoholism, Lyme disease, Syphilis, HIV, Hereditary disorders such as Charcot-Marie Tooth.\n* Patients not planned to receive Docetaxel therapy.\n* Patients who cannot communicate in English and unable to bring an interpreter will also be excluded.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}